B超在絕經(jīng)后卵巢腫瘤良惡性鑒別診斷中的臨床價值研究

打開文本圖片集

【摘要】目的：探討B(tài)超在絕經(jīng)后卵巢腫瘤良惡性鑒別診斷中的臨床價值。方法：回顧性納入2018年1月—2022年1月于本院診治的絕經(jīng)后卵巢腫瘤患者232例，均完成B超檢查和病理組織學(xué)檢查，并以病理組織學(xué)檢查為金標(biāo)準(zhǔn)，分析B超在絕經(jīng)后卵巢腫瘤良惡性鑒別診斷中的臨床效能。結(jié)果：232例患者中，B超檢查證實惡性66例，良性166例；病理組織學(xué)檢查證實惡性62例，良性170例；卵巢良惡性腫瘤B超檢查單雙側(cè)比例，形狀，腫瘤最大徑，腫瘤壁結(jié)構(gòu)，腹水，搏動指數(shù)及阻力指數(shù)比較差異有統(tǒng)計學(xué)意義（P

【關(guān)鍵詞】超聲；絕經(jīng)；卵巢腫瘤；鑒別診斷

Study on the clinical value of B-ultrasound in the differential diagnosis of benign and malignant postmenopausal ovarian tumors

XU Ailin， FAN Yumei， YANG Xingli

Nanchong Psychosomatic Hospital， Nanchong， Sichuan 637000， China

【Abstract】Objective To investigate the clinical value of B-ultrasound in the differential diagnosis of benign and malignant postmenopausal ovarian tumors. Methods 232 patients with postmenopausal ovarian tumor diagnosed and treated in our hospital from January 2018 to January 2022 were retrospectively included.All patients underwent B-ultrasound examination and histopathological examination，and the histopathological examination was used as the gold standard to analyze the clinical efficacy of B-ultrasound in the differential diagnosis of postmenopausal ovarian tumor between benign and malignant.Results Among 232 cases，B-ultrasound confirmed that66 cases were malignant and 166 cases were benign；Histopathological examination confirmed malignant for 62 cases and benign for 170 cases；There were statistically significant differences in unilateral and bilateral ratio， shape，maximum diameter of tumor， tumor wall structure， ascites，pulsatility index and resistance index of benign and malignant ovarian tumors by B-ultrasonography（P

【Key Words】Ultrasound； Menopause； Ovarian tumor； Differential diagnosis

絕經(jīng)后女性卵巢體積持續(xù)萎縮，激素水平明顯改變，卵巢惡性腫瘤發(fā)生風(fēng)險隨之增加[1]；有報道提示，卵巢癌發(fā)病率在絕經(jīng)后女性惡性腫瘤發(fā)病率中高居前三，且臨床預(yù)后極差，嚴(yán)重威脅患者生命安全[2]。（剩余4748字）